We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$30B
1-Year Est. Return
76.99%
This Fund
S&P 500
This Quarter
Est. Return
+43.51%
1 Year Est. Return
+76.99%
3 Year Est. Return
+326.24%
5 Year Est. Return
+435.69%
10 Year Est. Return
+2,724.6%
AUM
$30B
AUM Growth
+$7.24B
(+32%)
Cap. Flow
+$923M
Cap. Flow
% of AUM
3.08%
Top 10 Holdings %
Top 10 Hldgs %
54.41%
Holding
509
New
65
Increased
131
Reduced
225
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$982M |
| 2 |
NVIDIA
NVDA
|
+$276M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$211M |
| 4 |
Lumentum
LITE
|
+$203M |
| 5 |
Advanced Micro Devices
AMD
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NBIS
Nebius Group N.V.
NBIS
|
+$767M |
| 2 |
Astera Labs
ALAB
|
+$342M |
| 3 |
Western Digital
WDC
|
+$221M |
| 4 |
Intuitive Surgical
ISRG
|
+$121M |
| 5 |
AstraZeneca
AZN
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.55% |
| 2 | Communication Services | 18% |
| 3 | Industrials | 12.18% |
| 4 | Consumer Discretionary | 11.21% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Live Nation Entertainment
LYV
$39.7B
| $819K | ﹤0.01% |
4,470
-1,923
| -30% | -$316K |
|
377
Vicor
VICR
$8.91B
| $802K | ﹤0.01% |
+2,111
| New | +$576K |
|
378
Replimune Group
REPL
$1.39B
| $730K | ﹤0.01% |
+65,961
| New | +$404K |
|
|
SEPN
379
Septerna Inc
SEPN
$1.74B
| $702K | ﹤0.01% |
+20,958
| New | +$595K |
|
380
Mastercard
MA
$500B
| $670K | ﹤0.01% |
1,305
-489
| -27% | -$244K |
|
|
YSS
381
York Space Systems
YSS
$1.23B
| $662K | ﹤0.01% |
26,902
-41,879
| -61% | -$1.3M |
|
382
BioCryst Pharmaceuticals
BCRX
$2.32B
| $641K | ﹤0.01% |
64,112
-59,849
| -48% | -$541K |
|
383
HSBC
HSBC
$364B
| $633K | ﹤0.01% |
6,653
| – | – |
|
384
MoonLake Immunotherapeutics
MLTX
$1.27B
| $628K | ﹤0.01% |
+32,254
| New | +$585K |
|
385
Agilent Technologies
A
$41.4B
| $623K | ﹤0.01% |
4,681
+851
| +22% | +$104K |
|
386
Surrozen
SRZN
$243M
| $623K | ﹤0.01% |
24,004
-47,693
| -67% | -$1.31M |
|
|
MRX
387
Marex Group Limited Ordinary Shares
MRX
$5.52B
| $591K | ﹤0.01% |
9,695
-2,895
| -23% | -$159K |
|
388
Veralto
VLTO
$23.3B
| $566K | ﹤0.01% |
6,369
+1,158
| +22% | +$101K |
|
389
Ecolab
ECL
$78B
| $564K | ﹤0.01% |
2,019
+42
| +2% | +$11.1K |
|
|
MBX
390
MBX Biosciences
MBX
$3.03B
| $545K | ﹤0.01% |
+9,877
| New | +$345K |
|
391
UBS Group
UBS
$169B
| $530K | ﹤0.01% |
10,692
-7,395
| -41% | -$337K |
|
392
IDEAYA Biosciences
IDYA
$3.75B
| $524K | ﹤0.01% |
+14,063
| New | +$430K |
|
393
TAT Technologies
TATT
$523M
| $508K | ﹤0.01% |
10,535
-1,714
| -14% | -$68.8K |
|
394
Trimble
TRMB
$13.7B
| $505K | ﹤0.01% |
9,871
+4,854
| +97% | +$287K |
|
395
Kodiak Sciences
KOD
$2.2B
| $501K | ﹤0.01% |
12,865
-35,514
| -73% | -$1.38M |
|
396
Xylem
XYL
$25.4B
| $498K | ﹤0.01% |
4,209
+766
| +22% | +$88.4K |
|
397
Pennant Group
PNTG
$1.37B
| $465K | ﹤0.01% |
+12,589
| New | +$411K |
|
398
Corporacion America
CAAP
$3.95B
| $465K | ﹤0.01% |
18,461
-304
| -2% | -$7.81K |
|
399
ING
ING
$106B
| $447K | ﹤0.01% |
14,247
| – | – |
|
400
Tetra Tech
TTEK
$9.13B
| $432K | ﹤0.01% |
14,957
+2,720
| +22% | +$79.8K |
|
Similar funds
GMC
OAG
Fred Alger Management's Q2 2026 Portfolio in Review
As of Q2 2026, Fred Alger Management held 509 positions worth $30B, up 32% from $22.8B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Fred Alger Management deployed $923M of net new capital in Q2 2026, opening 65 new positions and adding to 131 existing holdings. Its largest new stake was SpaceX: 5,779,419 shares worth $987M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 39% a quarter earlier, followed by Communication Services and Industrials.
On the sell side, the largest reduction was Nebius Group N.V., an estimated $767M trimmed.
- Fred Alger Management's largest Q2 2026 buy was SpaceX: 5,779,419 shares worth $987M.
- Fred Alger Management added most to NVIDIA in Q2 2026, an estimated $276M increase.
- Fred Alger Management's biggest Q2 2026 reduction was Nebius Group N.V., cutting an estimated $767M.
- Fred Alger Management fully exited Palantir in Q2 2026, selling an estimated $95.2M.
- Fred Alger Management's ten largest holdings make up 54% of its $30B portfolio in Q2 2026.
- Fred Alger Management opened 65 new positions and closed 84 in Q2 2026.
- Fred Alger Management's portfolio value rose 32% quarter-over-quarter to $30B.
Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.